For example, the combination therapy of arginine metabolizing enzymes and immune checkpoint inhibitors increases intratumoral MHC expression and increases the presence of M1 phenotype macrophages, resulting in synergistic anti-tumor effects (48). The gene discussed is HLA-C; the disease is neoplasm.